MAGNITUDE Study of Niraparib/Abiraterone/Prednisone Shows Promise in mCRPC
ZYTIGA® (abiraterone acetate) For Healthcare Professionals
Steroid synthesis pathway and aromatization. Abiraterone is a novel... | Download Scientific Diagram
Dosage & Monitoring Considerations | ZYTIGA® (abiraterone acetate)
Abiraterone Acetate - an overview | ScienceDirect Topics
Dosage & Monitoring Considerations | ZYTIGA® (abiraterone acetate)
Clinical effectiveness of abiraterone acetate plus prednisone for the... | Download Scientific Diagram
Abiraterone in the management of castration-resistant prostate cancer prior to chemotherapy - Benjamin A. Gartrell, Fred Saad, 2015
Abiraterone acetate in the treatment of prostate cancer - ScienceDirect
A Phase II Study of Increased-Dose Abiraterone Acetate in Patients with Castration Resistant Prostate Cancer (CRPC)
Treatment Sequencing of Abiraterone Acetate plus Prednisone and Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer - touchONCOLOGY
Cancers | Free Full-Text | Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review
Zytiga Full Prescribing Information, Dosage & Side Effects | MIMS Hong Kong
Abiraterone: New Drug in the Treatment of Metastatic Castration-resistant Prostate Cancer - The ASCO Post
Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid Glucuronidation | Drug Metabolism & Disposition
Clinical Evaluation of Abiraterone in the Treatment of Metastatic Prostate Cancer - Jatinder Goyal, Emmanuel S. Antonarakis, 2013
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy | NEJM
FORCE | Abiraterone/Prednisone and Olaparib Alone or In Combination for Treatment of Metastatic Castration-Resistant Prostate Cancer With Mutations Related to DNA Repair
Fatigue, quality of life and metabolic changes in men treated with first-line enzalutamide versus abiraterone plus prednisolone for metastatic castration-resistant prostate cancer (HEAT): a randomised trial protocol | BMJ Open
APCCC 2019: Optimal Steroid Use with Abiraterone
Abiraterone: New Drug in the Treatment of Metastatic Castration-resistant Prostate Cancer - The ASCO Post
Unexpected Race-Based Findings in Novel Prostate Cancer Study | MedPage Today
Abirateron – Wikipedia
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design -
Abiraterone Acetate | SpringerLink
